文献速递呼吸衰竭与机械通气儿科与产科急症重症综合管理与镇静镇痛

暴露于儿童急性呼吸窘迫综合征患儿气道液的CD4+ T细胞RNA测序分析

RNA Sequencing Analysis of CD4+ T Cells Exposed to Airway Fluid From Children With Pediatric Acute Respiratory Distress Syndrome.
PubMed 文献 · Crit Care Explor · 2023-06-23
一句话结论在体外报告基因检测中,暴露于重症PARDS患儿气道液的CD4+ T细胞先天免疫、I型(α和β)及II型(γ)干扰素反应和细胞因子/趋化因子信号通路下调,需验证。

该研究为体外先导研究,采用新型转录组报告基因检测,将供体CD4+ T细胞暴露于36张床的大学附属儿科重症监护病房收治的插管患儿气道液。纳入7例重症PARDS、9例轻度PARDS和4例无肺损伤的插管对照。对CD4+ T细胞进行bulk RNA测序,发现与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中先天免疫通路、I型(α和β)及II型(γ)干扰素反应和细胞因子/趋化因子信号下调。作者认为这些通路将推动PARDS机制研究,需要用该转录组报告基因检测策略验证。

要点

  • 研究纳入7例重症PARDS、9例轻度PARDS和4例无肺损伤插管对照,采用体外CD4+ T细胞转录组报告基因检测。
  • 与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中先天免疫通路下调。
  • 与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中I型(α和β)和II型(γ)干扰素反应下调。
  • 与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中细胞因子/趋化因子信号下调。
  • 作者认为这些通路将推动PARDS机制研究,需要用该转录组报告基因检测策略验证。

适用人群与场景

  • 插管儿童,包括7例重症PARDS、9例轻度PARDS和4例无肺损伤的插管对照,气道液样本来自36张床的大学附属儿科重症监护病房收治的患儿。

研究设计与关键结果

  • 研究设计为体外先导研究,采用新型转录组报告基因检测,将供体CD4+ T细胞暴露于插管儿童气道液,进行bulk RNA测序。
  • 与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中先天免疫通路下调。
  • 与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中I型(α和β)和II型(γ)干扰素反应下调。
  • 与轻度PARDS相比,重症PARDS气道液暴露的CD4+ T细胞中细胞因子/趋化因子信号下调。

证据类型、等级与局限

  • 证据类型:体外先导研究。
  • 局限:作者指出需要用该转录组报告基因检测策略验证这些发现。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: CD4+ T cells contribute to lung inflammation in acute respiratory distress syndrome. The CD4+ T-cell response in pediatric acute respiratory distress syndrome (PARDS) is unknown.

OBJECTIVES: To identify differentially expressed genes and networks using a novel transcriptomic reporter assay with donor CD4+ T cells exposed to the airway fluid of intubated children with mild versus severe PARDS.

DESIGN: In vitro pilot study.

SETTING: Laboratory-based study using human airway fluid samples admitted to a 36-bed university-affiliated pediatric intensive care unit.

PATIENTS/SUBJECTS: Seven children with severe PARDS, nine children with mild PARDS, and four intubated children without lung injury as controls.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We performed bulk RNA sequencing using a transcriptomic reporter assay of CD4+ T cells exposed to airway fluid from intubated children to discover gene networks differentiating severe from mild PARDS. We found that innate immunity pathways, type I (α and β), and type II (γ) interferon response and cytokine/chemokine signaling are downregulated in CD4+ T cells exposed to airway fluid from intubated children with severe PARDS compared with those with mild PARDS.

CONCLUSIONS: We identified gene networks important to the PARDS airway immune response using bulk RNA sequencing from a novel CD4+ T-cell reporter assay that exposed CD4+ T cells to airway fluid from intubated children with severe and mild PARDS. These pathways will help drive mechanistic investigations into PARDS. Validation of our findings using this transcriptomic reporter assay strategy is needed.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Ripple MJ, Huang M, Stephenson ST, et al. RNA Sequencing Analysis of CD4+ T Cells Exposed to Airway Fluid From Children With Pediatric Acute Respiratory Distress Syndrome. Crit Care Explor. 2023. PMID: 37378084. doi:10.1097/CCE.0000000000000935

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。